← Eichor
Condition: Cerebellar Atrophy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cerebellar Atrophy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The CurePSP Genetics Program
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT06647641Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant
NA · 1 location(s) · University of Salerno · NCT06821256Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
NA · 1 location(s) · Centre Hospitalier Universitaire de Liege · NCT07136844Sporadic Degenerative Ataxia With Adult Onset: Natural History Study
Phase N/A · 14 location(s) · Ataxia Study Group · NCT02701036Modifiable Variables in Parkinsonism (MVP)
Phase N/A · 1 location(s) · Bastyr University · NCT02194816The Myelin Disorders Biorepository Project
Phase N/A · 23 location(s) · Children's Hospital of Philadelphia · NCT03047369Development, Application, and Mechanistic Investigation of a Novel Minimally-Invasive Bidirectional Epidural Cerebellar
Phase N/A · 1 location(s) · Peking University First Hospital · NCT07166432Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases
Phase N/A · 1 location(s) · Hadassah Medical Organization · NCT00874783Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.